People
Researchers, students and alumni of YAS Lab.
Principal investigator
Yao-An Shen, PhD
Associate Professor · Department of Pathology / Graduate Institute of Clinical Medicine / International Master/PhD Program in Medicine, College of Medicine, Taipei Medical University
Dr. Yao-An Shen graduated with first-class honors from the PhD program in Biochemistry and Molecular Biology at National Yang-Ming University, Taiwan. His passion for cancer research led him to Johns Hopkins University for postdoctoral training, where he specialized in cancer stem cells (CSCs) and translational research.
Determined to bridge fundamental science and clinical applications, he focused on unraveling the mechanisms of CSCs – a chemoresistant, recurrent, and metastatic tumor subset. His mission is to develop innovative therapeutic strategies, spanning immune cell therapy, transcription factor inhibitors, and nanomedicine.
Dr. Shen's work has earned him membership in Sigma Xi and nine Young Investigator Awards. He has published in journals such as Blood, ACS Nano, Cancer Research, EBioMedicine, J Exp Clin Cancer Res, and Cell Reports. Beyond academia, he holds over 10 patents in cell therapy, small molecule drugs, vesicular drugs, and nanoparticle drugs. In 2024, he founded Enlighten Biomedicine, a biotechnology company translating CSC research into medical applications.
As an associate professor at Taipei Medical University, he continues to advance cancer stem cell research and the development of next-generation oncology treatments.
Education
- 2009–2015PhD, Institute of Biochemistry and Molecular Biology, National Yang-Ming University
- 2007–2009MS, Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University
- 2000–2004BS, Department of Life Science, Tzu Chi University
Research specialties
- Translational Research — Small molecule inhibitors targeting GLS and PBX1 as cancer therapeutics
- Cell Therapy — Stem cells for regenerative medicine and immune cells for anti-cancer therapy
- Cancer Metabolism — Metabolic compensation and the microenvironmental landscape of therapy-resistant cells
- Cancer Stem Cell Research — Metabolic reprogramming of cancer stem cells and biomarker discovery for targeted therapy
- Induced Pluripotent Stem Cells — Metabolic reprogramming and anti-cancer applications of iPSCs
- Nanomedicine — Targeted delivery systems of nanobiomaterials for cancer stem cell treatment
Experience
- 2024.02–presentAssociate Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
- 2019.06–2024.02Assistant Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
- 2016.08–2019.06Postdoctoral Fellow, Departments of Pathology, Oncology, and Gynecology & Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
- 2015.08–2016.07Postdoctoral Fellow, Department of Biomedical Engineering, National Yang-Ming University
- 2015.02–2015.07Postdoctoral Fellow, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital
Teaching
General Biology, General Chemistry, Biochemistry and Molecular Biology, Molecular Pathology, Genetics, Bioenergetics and Metabolism, Cancer Stem Cell Biology, Stem Cell Biology, Translational Medicine, Development of Cancer Therapeutics, Problem-Based Learning, Critical Thinking and Research Design
Grants (10)
- 2025.01–2029.12PI — Development of Acid-Responsive Mesoporous Silica Nanoparticles for Delivery of PBX1 Inhibitors Targeting Cancer Stem Cell Transcriptional Activity
- 2024.08–2028.07PI — Utilizing Glucosamine-Labeled Nanodrugs as a Novel Pancreatic Cancer Stem Cell Therapy to Counteract Metabolic Compensation and Synergistically Inhibit Transcriptional Activity
- 2024.01–2024.12PI — Commercial Applications of Technique Platform Development for Cancer Stem Cell Isolation and Cell Therapy
- 2023.08–2024.07PI — Investigation on the Synergistic Effect of a Combination of PCSK9 Inhibitors and Hyperthermia in Hepatic Cancer Stem Cells
- 2023.01–2023.12PI — Technique Platform Development for Cancer Stem Cell Isolation and Cell Therapy
- 2022.08–2023.07PI — Development of First-in-class Transcription Factor Drug Targeting Cancer Stem Cells
- 2021.04–2022.04Co-PI — Investigation of Hyperthermia Effects on Tumor Metabolism and Microenvironment in Radioresistant Bladder Cancer
- 2020.12–2023.11PI — Investigation of Metabolic Isolation of Stem Cells and Its Effects on Differentiation Therapy of Cancer Stem Cells
- 2020.02–2022.07PI — Reversing Metabolic Compensation to Overcome Recurrence in Ovarian Cancer by Inhibition of MYC/GLS Axis
- 2019.09PI — Research Grants for Newly Hired Faculty
Honors & awards (14)
- 2024.08Elected full member of Sigma Xi, the Scientific Research Honor Society
- 2023.05Licensing & technology transfer of 8 patents on cell expansion and metabolic selection techniques (I CARE YOU Biotech)
- 2016.11Postdoctoral Research Abroad Program (PRAP) Award, Ministry of Science and Technology, Taiwan
- 2013.11Young Investigator Award, International Symposium on Mitochondria 2013 / 13th Conference of J-mit, Japan
- 2013.11Young Investigator Award, 10th Conference of the Asian Society of Mitochondrial Research and Medicine (ASMRM), Korea
- 2013.10First Prize, Poster Award, 2013 Mini-symposium on Mitochondria and Aging, Taiwan
- 2013.10Young Investigator Award, 6th Biennial Meeting of SFRR-Asia, Taiwan
- 2013.09Third Prize, Poster Award, 2013 International Symposium on Mitochondrial Dynamics in Translational Medicine, Taiwan
- 2012.11Young Investigator Award, 9th ASMRM Conference, Beijing, China
- 2012.10Silver Medal, Oral Session Competition, 7th International Symposium on Genomic Medicine of CCH, Taiwan
- 2011.10Fellowship Award, 22nd FAOBMB Conference, Singapore
- 2011.08Young Investigator Award, 8th ASMRM Conference, Kagoshima, Japan
- 2011.07First Prize, Poster Award, 2011 Mackay International Symposium on Mitochondrial Medicine, Taipei, Taiwan
- 2010.12Young Investigator Award, 7th ASMRM Conference, Fukuoka, Japan
Patents (5)
- 2024.12A method for expanding circulating tumor cells and applications thereof
- 2024.10Cancer stem cell serum-free conditioned medium, and use thereof in a quadruple selecting method for cancer stem cell line, and the isolated cancer stem cell line
- 2024.09PRP-plus and its preparation method and use
- 2024.05Peripheral blood stem cell amplification method
- 2021.08Monosaccharide-tagged nano-liposome drug delivery system, the manufacture and use for drug targeting delivery thereof
Current members
Current members
Staff 4
-

Hung-Chung Chang
Postdoctoral Fellow
Business Development
-

George Cheng
Researcher
R&D
-

Ho Thi Luu
Postdoctoral Fellow
-

Kyle Cheng
MD
R&D
Graduate Students 7
-

Ray Chang
PhD Student
-

Yuyu Rahayu Arifin
PhD Student
-

Dinesh Kute
PhD Student
-

Eman Fatima
PhD Student
-

Yuki
PhD Student
-

Nguyen Dinh Thien
PhD Student
-

Jamie Lin
MS Student · Lab Manager
Medical Students 12
-
Allison莊晰之
Medical Student
-
Albert吳道賢
Medical Student
-
Heidi李彩禕
Medical Student
-
Tiffany曾馨儀
Medical Student
-
Angelina陳安晴
Medical Student
-
Mina洪子宸
Medical Student
-
Mimi楊岱穎
Medical Student
-
Amber林詠芯
Medical Student
-
Maus陳竤宇
Medical Student
-
Andy許和晏
Medical Student
-
Anna楊詠晴
Medical Student
-
Keynes邱楷恩
Medical Student
Alumni
Alumni
-

Ho Thi Luu
PhD Program
2022–2026
NowPostdoctoral Fellow at YAS Lab
-

Viet-Cuong Nguyen
PhD Program
2023–2026
Now—
-

Jane Tien Phan
Master's Student
2023–2025
Now—
-

Liang-Yun Chen
Medical Student
2023–2025
NowPGY at SHH
-

Ting-Wan Kao
Master's Student
2023–2024
NowMaster's student at Harvard Medical School
-

Geng-Hao Bai
Medical Student
—
NowResident at NTUH